Dudediligence.

Werewolf Therapeutics, Inc

HOWLNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

48.6M

on 2026-06-30, from 43.3M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

S-3 of 2025-05-08. Not read yet. S-3 ↗

3 of its filings are not read yet.

Warrants

The 10-Q filed 2026-07-31 is not read yet.

Cash

2.9 quarters

$22.0M on 2026-06-30 ÷ $7.5M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-08-21Private placementnot readnot read$150.0M8-K ↗